share_log

Winning Health Technology Group (SZSE:300253) investors are up 3.6% in the past week, but earnings have declined over the last five years

Winning Health Technology Group (SZSE:300253) investors are up 3.6% in the past week, but earnings have declined over the last five years

贏利健康科技集團(SZSE:300253)的投資者在過去一週上漲了3.6%,但收益在過去五年裏有所下降
Simply Wall St ·  2022/06/22 01:27

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking involves risks (and requires diversification) it can also provide excess returns. For example, the Winning Health Technology Group Co., Ltd. (SZSE:300253) share price is up 45% in the last 5 years, clearly besting the market return of around 11% (ignoring dividends).

選股人士一般都在尋找表現好於大盤的股票。雖然主動選股會帶來風險(並需要分散投資),但它也可以提供超額回報。例如,贏利健康科技集團有限公司。(SZSE:300253)股價在過去5年中上漲了45%,顯然超過了約11%的市場回報率(不考慮股息)。

Since the stock has added CN¥666m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由於僅在過去一週,該股市值就增加了6.66億元人民幣,讓我們看看潛在表現是否一直在推動長期回報。

Check out our latest analysis for Winning Health Technology Group

查看我們對贏得健康技術組的最新分析

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

雖然市場是一種強大的定價機制,但股價反映的是投資者情緒,而不僅僅是潛在的企業表現。通過比較每股收益(EPS)和股價隨時間的變化,我們可以感受到投資者對一家公司的態度隨着時間的推移發生了怎樣的變化。

During five years of share price growth, Winning Health Technology Group actually saw its EPS drop 6.5% per year.

在股價增長的五年中,獲勝的健康科技集團實際上看到其每股收益每年下降6.5%。

This means it's unlikely the market is judging the company based on earnings growth. Because earnings per share don't seem to match up with the share price, we'll take a look at other metrics instead.

這意味着市場不太可能根據盈利增長來評判該公司。由於每股收益似乎與股價不匹配,我們將轉而看看其他指標。

The modest 0.2% dividend yield is unlikely to be propping up the share price. On the other hand, Winning Health Technology Group's revenue is growing nicely, at a compound rate of 21% over the last five years. In that case, the company may be sacrificing current earnings per share to drive growth.

0.2%的適度股息收益率不太可能支撐股價。另一方面,Winning Health Technology Group的收入增長良好,過去五年的複合增長率為21%。在這種情況下,該公司可能是在犧牲當前的每股收益來推動增長。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到收益和收入隨時間的變化(單擊圖表查看確切的值)。

SZSE:300253 Earnings and Revenue Growth June 22nd 2022
深交所:2022年6月22日收益和收入增長300253

This free interactive report on Winning Health Technology Group's balance sheet strength is a great place to start, if you want to investigate the stock further.

免費如果你想進一步調查健康科技集團的股票,那麼關於贏得健康科技集團資產負債表實力的互動報告是一個很好的起點。

A Different Perspective

不同的視角

We regret to report that Winning Health Technology Group shareholders are down 41% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 8.0%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 8% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Winning Health Technology Group better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Winning Health Technology Group you should know about.

我們遺憾地報告,贏得健康科技集團的股東今年以來下降了41%(甚至包括股息)。不幸的是,這比大盤8.0%的跌幅還要糟糕。然而,這可能只是因為股價受到了更廣泛的市場緊張情緒的影響。也許有必要關注基本面,以防出現良機。好的一面是,長期股東已經賺到了錢,過去五年的年回報率為8%。最近的拋售可能是一個機會,因此可能值得查看基本面數據,以尋找長期增長趨勢的跡象。跟蹤股價的長期表現總是很有趣的。但要更好地理解贏下健康科技集團,我們還需要考慮許多其他因素。例如,考慮一下風險。每家公司都有它們,我們已經發現健康科技組獲獎的2個警示標誌你應該知道。

We will like Winning Health Technology Group better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些大的內部收購,我們會更喜歡贏得健康科技集團。在我們等待的時候,看看這個免費最近有大量內幕收購的成長型公司名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.

請注意,本文引用的市場回報反映了目前在CN交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論